Economic evaluation in patient safety: A literature review of methods

BMJ Quality and Safety

Volumn 21, Issue 6, 2012, Pages 457-465

  De Rezende, Bruna Alves ^a,b   Or, Zeynep ^b   Com Ruelle, Laure ^b   Michel, Philippe ^a  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

^b Institut de Recherche et de Documentation en Economie de la Santé Irdes   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; COST BENEFIT ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE QUALITY; HUMAN; MEDICATION ERROR; MEDLINE; PATIENT SAFETY; REVIEW; SYSTEMATIC REVIEW;

COSTS AND COST ANALYSIS; HUMANS; PATIENT SAFETY;

EID: 84861801283     PISSN: 20445415     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmjqs-2011-000191     Document Type: Review

References (59)

1. Kohn LT, Corrigan J, Donaldson MS, eds. To Err is Human: Building a Safer Health System. Washington DC: National Academy Press, 2000.
2. Thomas EJ, Studdert DM, Newhouse JP, et al. Costs of medical injuries in Utah and Colorado. Inquiry 1999;36:255-64.
3. Thomas EJ, Studdert DM, Burstin HR, et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care 2000;38:261-71.
4. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients. Results of the Harvard Medical Practice Study I. N Engl J Med 1991;324:370-6.
5. Arah OA, Westert GP, Hurst J, et al. A conceptual framework for the OECD health care quality indicators project. Int J Qual Health Care 2006;18(Suppl 1):5-13. (Pubitemid 44417940)
6. Zikos D, Diomidous M, Mantas J. A framework for the development of patient safety education and training guidelines. Stud Health Technol Inform 2010;155:189-95.
7. World Alliance for Patient Safety. Implementation Manual. Surgical Safety Checklist. Geneva: World Health Organisation, 2009.
8. World Alliance for Patient Safety. Save Lives, Clean Your Hands. A Guide to the Implementation of the WHO Multimodal Hand Hygiene Improvement Strategy. Geneva: World Health Organisation, 2009.
9. World Alliance for Patient Safety. The Conceptual Framework for the International Classification for Patient Safety. Geneva: World Health Organization, 2009.
10. Van Den Bos J, Rustagi K, Gray T, et al. The $17.1 billion problem: the Annual cost of Measurable medical errors. Health Aff 2011;30:596-603.
11. Agency for Health Care Research and Quality. Assessing the Evidence Base for Context-sensitive Effectiveness and Safety of Patient Safety Practices: Developing Criteria. http://www.ahrq.gov/qual/contextsensitive/context1.htm (accessed 15 Sep 2010).
12. Dy SM, Taylor SL, Carr LH, et al. A framework for classifying patient safety practices: results from an expert consensus process. BMJ Qual Saf 2011;20:618-24.
13. Ovretveit J. Does improving quality save money? The Health Foundation. 2009. http://www.health.org.uk/publications/research-reports/does-quality-save. html (accessed 29 Mar 2010).
14. Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990-2000. Am J Infect Control 2002;30:145-52. (Pubitemid 34521457)
15. Scott R. The Direct Medical Costs of Healthcare-associated Infections in U.S. Hospitals and the Benefits of Prevention. Atlanta: CDC, 2009.
16. Stone PW, Braccia D, Larson E. Systematic review of economic analyses of health care-associated infections. Am J Infect Control 2005;33:501-9. (Pubitemid 41551611)
17. Pirson M, Dramaix M, Struelens M, et al. Costs associated with hospital-acquired bacteraemia in a Belgian hospital. J Hosp Infect 2005;59:33-40. (Pubitemid 39618963)
18. Clark R. Trends influencing the cost of care and patient safety. Decision-making in five key areas can improve clinical and economic performance. Health Manag Technol 2006;27:18, 20-1.
19. Penel N, Lefebvre JL, Cazin JL, et al. Additional direct medical costs associated with nosocomial infections after head and neck cancer surgery: a hospital-perspective analysis. Int J Oral Maxillofac Surg 2008;37:135-9. (Pubitemid 351220977)
20. MacLaren R, Bond CA, Martin SJ, et al. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections. Crit Care Med 2008;36:3184-9.
21. Graves N. Economics and preventing hospital-acquired infection. Emerging Infect Dis 2004;10:561-6. (Pubitemid 38420284)
22. Chodick G, Ashkenazi S, Livni G, et al. Cost-effectiveness of varicella vaccination of healthcare workers. Vaccine 2005;23:5064-72. (Pubitemid 41318154)
23. Roberts RR, Scott RD, Cordell R, et al. The use of economic modeling to determine the hospital costs associated with nosocomial infections. Clin Infect Dis 2003;36:1424-32. (Pubitemid 36702877)
24. Hoonhout LHF, de Bruijne MC, Wagner C, et al. Direct medical costs of adverse events in Dutch hospitals. BMC Health Serv Res 2009;9:27.
25. Fukuda H, Imanaka Y, Hayashida K. Cost of hospital-wide activities to improve patient safety and infection control: a multi-centre study in Japan. Health Policy 2008;87:100-11.
26. Fukuda H, Imanaka Y, Hirose M, et al. Economic evaluations of maintaining patient safety systems in teaching hospitals. Health Policy 2008;88:381-91.
27. Nuckols TK, Escarce JJ. Residency work-hours reform. A cost analysis including preventable adverse events. J Gen Intern Med 2005;20:873-8. (Pubitemid 41726668)
28. Wang SJ, Middleton B, Prosser LA, et al. A cost-benefit analysis of electronic medical records in primary care. Am J Med 2003;114:397-403. (Pubitemid 36513689)
29. Cosgrove SE, Qi Y, Kaye KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166-74. (Pubitemid 40445022)
30. de Lissovoy G, Fraeman K, Hutchins V, et al. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009;37:387-97.
31. Dietrich ES, Demmler M, Schulgen G, et al. Nosocomial pneumonia: a cost-of-illness analysis. Infection 2002;30:61-7. (Pubitemid 34293368)
32. Eber MR, Laxminarayan R, Perencevich EN, et al. Clinical and economic outcomes attributable to health care-associated sepsis and pneumonia. Arch Intern Med 2010;170:347-53.
33. Gianino MM, Vallino A, Minniti D, et al. A model for calculating costs of hospital-acquired infections: an Italian experience. J Health Organ Manag 2007;21:39-53.
34. Graves N, Nicholls TM, Morris AJ. Modeling the costs of hospitalacquired infections in New Zealand. Infect Control Hosp Epidemiol 2003;24:214-23. (Pubitemid 36383459)
35. Herwaldt LA, Cullen JJ, Scholz D, et al. A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections. Infect Control Hosp Epidemiol 2006;27:1291-8. (Pubitemid 46052274)
36. Kilgore M, Brossette S. Cost of bloodstream infections. Am J Infect Control 2008;36:S172.e1-3.
37. Kim T, Oh PI, Simor AE. The economic impact of methicillin-resistant Staphylococcus aureus in Canadian hospitals. Infect Control Hosp Epidemiol 2001;22:99-104. (Pubitemid 32157160)
38. Larue A, Loos-Ayav C, Jay N, et al. Effets sur la morbidité et les coÛts des pneumopathies nosocomiales à Staphilococcus aureus résistant à la méthicilline en réanimation. Presse Med 2009;38:25-33.
39. Plowman R, Graves N, Griffin MA, et al. The rate and cost of hospitalacquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198-209. (Pubitemid 32631848)
40. Sánchez-Velázquez LD, Ponce de León Rosales S, Rangel Frausto MS. The burden of nosocomial infection in the intensive care unit: effects on organ failure, mortality and costs. A nested case-control study. Arch Med Res 2006;37:370-5.
41. Sheng WH, Chie WC, Chen YC, et al. Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients. J Formos Med Assoc 2005;104:318-26.
42. Weber WP, Zwahlen M, Reck S, et al. Economic burden of surgical site infections at a European university hospital. Infect Control Hosp Epidemiol 2008;29:623-9. (Pubitemid 352009387)
43. Wisplinghoff H, Cornely OA, Moser S, et al. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study. Infect Control Hosp Epidemiol 2003;24:905-11. (Pubitemid 38029557)
44. Wilson SJ, Knipe CJ, Zieger MJ, et al. Direct costs of multidrug-resistant Acinetobacter baumannii in the burn unit of a public teaching hospital. Am J Infect Control 2004;32:342-4. (Pubitemid 39348964)
45. Stone PW, Hasan S, Quiros D, et al. Effect of guideline implementation on costs of hand hygiene. Nurs Econ 2007;25:279-84.
46. Calugar A, Ortega-Sánchez IR, Tiwari T, et al. Nosocomial pertussis: costs of an outbreak and benefits of vaccinating health care workers. Clin Infect Dis 2006;42:981-8.
47. Vriens M, Blok H, Fluit A, et al. Costs associated with a strict policy to eradicate methicillin-resistant Staphylococcus aureus in a Dutch University Medical Center: a 10-year survey. Eur J Clin Microbiol Infect Dis 2002;21:782-6. (Pubitemid 35435699)
48. Brown C, Lilford R. Should the UK government's deep cleaning of hospitals programme have been evaluated? J Infect Prev 2009;10:143-7.
49. van Rijen MML, Kluytmans JAJW. Costs and benefits of the MRSA search and destroy policy in a Dutch hospital. Eur J Clin Microbiol Infect Dis 2009;28:1245-52.
50. Vargas E, Terleira A, Hernando F, et al. Effect of adverse drug reactions on length of stay in surgical intensive care units. Crit Care Med 2003;31:694-8. (Pubitemid 36379570)
51. Kopp BJ, Mrsan M, Erstad BL, et al. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist. Am J Health Syst Pharm 2007;64:2483-7. (Pubitemid 350209839)
52. Rapp RP, Evans ME, Martin C, et al. Drug costs and bacterial susceptibility after implementing a single-fluoroquinolone use policy at a university hospital. Curr Med Res Opin 2004;20:469-76. (Pubitemid 38525155)
53. Weeks WB, Mills PD, Dittus RS, et al. Using an improvement model to reduce adverse drug events in VA facilities. Jt Comm J Qual Improv 2001;27:243-54.
54. Wu RC, Laporte A, Ungar WJ. Cost-effectiveness of an electronic medication ordering and administration system in reducing adverse drug events. J Eval Clin Pract 2007;13:440-8. (Pubitemid 46789651)
55. Karnon J, McIntosh A, Dean J, et al. Modelling the expected net benefits of interventions to reduce the burden of medication errors. J Health Serv Res Policy 2008;13:85-91. (Pubitemid 351702972)
56. Harbrecht BG, Delgado E, Tuttle RP, et al. Improved outcomes with routine respiratory therapist evaluation of non-intensive-care-unit surgery patients. Respir Care 2009;54:861-7.
57. Raftery J. Costing in economic evaluation. BMJ 2000;320:1597. (Pubitemid 30336099)
58. Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA 2003;290:1868-74. (Pubitemid 37430603)
59. Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the Economic Evaluation of Health Care Programmes. 3rd edn. Oxford, UK: Oxford University Press, 2005.